top of page

Resources

Search

Cannabis Guidance Comments

  • Sep 23, 2020
  • 1 min read

Comments from the Collaborative for CBD Science and Safety on “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research” (FDA-2020-D-1079)


Click here to view the PDF.

Comments

The Collaborative for Cannabinoid Science and Safety | Privacy Policy

© 2023 Collaborative for Cannabinoid Science and Safety. All rights Reserved.

bottom of page